Last checked at 23 Dec 2016 10:48
Director / PDMR Shareholding
23 December 2016
Genedrive plc (the "Company")
| 1. | Details of PDMR | |||||
| (a) | Name | Matthew Fowler | ||||
| (b) | Position/status | Chief Financial Officer | ||||
| (c) | Initial notification/amendment | Initial notification | ||||
| 2. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
| (a) | Description of the financial instrument | Options over ordinary shares of 1.5 pence each. | ||||
| (b) | Nature of the transaction | Grant of options pursuant to and in accordance with the terms of the Company's Share Option Scheme dated 28 November 2007. | ||||
| (c) | Price(s) and volume(s) |
| ||||
| (d) | Aggregated informationAggregated volumePrice | N/A | ||||
| (e) | Date of the transaction | 22 December 2016 | ||||
| (f) | Place of the transaction | Outside trading venue - shares to be admitted to AIM market of London Stock Exchange plc on exercise of options. | ||||
For further details please contact:
genedrive plc
David Budd: CEO +44 (0)161 989 0245
Peel Hunt LLP
James Steel +44 (0)207 418 8900
Oliver Jackson
Consilium Strategic Communications
Chris Gardner +44 (0)203 709 5700
Matthew Neal
Laura Thornton
genedrive@consilium-comms.com